✦ LIBER ✦

Phase II combination of gefitinib and docetaxel for advanced or metastatic non-small cell lung cancer: clinical results and biological monitoring

✍ Scribed by M. Gatineau; E. Dansin; F. Chomy; E. Lemarie; P. Nouyrigat; S. Oudard; R. Mouawad; A. Tisseron Carrasco; D. Khayat; O. Rixe

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of docetaxel and cisplati

✍ Y. H. Kim; J. S. Kim; Y. H. Choi; K. H. In; H. S. Park; D. S. Hong; T. J. Jeong; 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 67 KB

Second-line therapy with gefitinib in co

✍ G. Robinet; F. Barlesi; P. Fournel; H. Berard; R. Corre; A. Vergnenegre; L. Falc 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 160 KB

Carboplatin and docetaxel in advanced no

✍ Sakkaraiappan Ramalingam; TracyW. Dobbs; AviI. Einzig; Slawomir Wojtowicz-Praga; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 181 KB

Phase II study of S-1 and docetaxel for

✍ Kazuhiro Yanagihara; Kenichi Yoshimura; Miyuki Niimi; Hiroyasu Yasuda; Takahiko 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 260 KB

Phase II study of docetaxel and cisplati

✍ H. Okamoto; K. Watanabe; Y. Segawa; Y. Ichinose; A. Yokoyama; S. Yoneda; H. Niit 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 86 KB

Front-line paclitaxel and topotecan chem

✍ G. P. Stathopoulos; C. Katis; D. Tsavdaridis; J. Dimitroulis; D. Karaindros; J. 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 217 KB